PTEN and cancer: Although genetic mutation of PTEN is frequent across many cancer types1,2, the loss of PTEN activity in cancer more often occurs in the absence of mutation through complex mechanisms including epigenetic transcriptional repression, microRNAs, noncoding RNAs, and posttranslational modifications, among others3–7.